




Searching News Database: Duramed Pharmaceuticals
HSMN NewsFeed - 27 Apr 2012
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
Watson Announces Restructuring of Senior Leadership to Support Expanded Global Businesses
HSMN NewsFeed - 16 Sep 2009
Plan B(R) One-Step Emergency Contraception Now Available At U.S. Pharmacies
Plan B(R) One-Step Emergency Contraception Now Available At U.S. Pharmacies
HSMN NewsFeed - 29 Dec 2008
Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
HSMN NewsFeed - 20 Aug 2008
Barr Announces Approval of Generic Aredia(R) Injection, 30mg/mL, 60mg/mL and 90mg/mL Injectable
Barr Announces Approval of Generic Aredia(R) Injection, 30mg/mL, 60mg/mL and 90mg/mL Injectable
HSMN NewsFeed - 29 Jul 2008
Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
Barr Confirms Patent Challenge of Sensipar(R) Tablets, 30mg, 60mg and 90mg
HSMN NewsFeed - 19 Feb 2008
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
Barr Receives Final Approval for Generic Mirapex(R) Tablets, 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg
HSMN NewsFeed - 14 Dec 2007
Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
Barr Subsidiary Sues Watson and Sandoz for SEASONALE(R) Patent Infringement
HSMN NewsFeed - 2 Aug 2007
Barr Announces Departure of President and COO; CEO Downey to Assume Responsibilities
Barr Announces Departure of President and COO; CEO Downey to Assume Responsibilities
HSMN NewsFeed - 16 Jul 2007
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
Barr Confirms Patent Challenge of Xopenex(R) Inhalation Solution, 0.31mg/3mL, 0.63mg/3mL and 1.25mg/3mL
HSMN NewsFeed - 4 Jun 2007
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)
Barr and Eli Lilly Voluntarily Dismiss Patent Litigation on Prozac(R) Weekly(TM)
HSMN NewsFeed - 11 May 2007
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
Barr Receives Tentative Approval for a Generic Version of Razadyne(R) Tablets, 4mg, 8mg and 12mg
HSMN NewsFeed - 30 Apr 2007
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
Duramed's ENJUVIA(TM) (Synthetic Conjugated Estrogens, B) Tablets Receives Two New FDA Approvals
HSMN NewsFeed - 20 Mar 2007
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
Barr Confirms Filing an Application with a Paragraph IV Certification for ABILIFY(R) Tablets
HSMN NewsFeed - 6 Feb 2007
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
HSMN NewsFeed - 23 Jan 2007
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
Barr's Subsidiary PLIVA Receives Approval for Generic ZITHROMAX(R) IV, 500 mg Vial
HSMN NewsFeed - 19 Jan 2007
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
Barr Launches Generic METAGLIP(TM) Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg
HSMN NewsFeed - 18 Jan 2007
Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
Barr Receives Tentative Approval for Generic KYTRIL(R) Tablets, 1mg (Base)
HSMN NewsFeed - 6 Nov 2006
Barr Launches Plan B(R) OTC/Rx Dual-Label Product; Awarded 3 Years New Product Exclusivity
Barr Launches Plan B(R) OTC/Rx Dual-Label Product; Awarded 3 Years New Product Exclusivity
HSMN NewsFeed - 20 Oct 2006
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
Barr Acquires PLIVA d.d. Following Official Closing of Tender Offer Process
HSMN NewsFeed - 18 Sep 2006
U.S. Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits
U.S. Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits
HSMN NewsFeed - 7 Sep 2006
Barr Launches a Generic Version of its SEASONALE(R) Extended-Cycle Oral Contraceptive
Barr Launches a Generic Version of its SEASONALE(R) Extended-Cycle Oral Contraceptive
HSMN NewsFeed - 7 Sep 2006
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
Watson Pharmaceuticals Receives FDA Final Approval for Generic Seasonale(R)
Additional items found! 64

Members Archive contains
64 additional stories matching:
Duramed Pharmaceuticals
(Password required)
Duramed Pharmaceuticals
(Password required)